News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Specialty Pharmaceutical Management Consulting Firm Viscadia Hires Bruce Yeager



2/11/2014 1:56:56 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Washington, DC – February 11, 2014 – Specialty pharmaceutical management consulting firm Viscadia Inc. has hired Bruce Yeager, formerly of Savient Pharmaceuticals, as a managing consultant. Yeager has more than 23 years of experience in various senior-level commercial pharmaceutical roles, working for large, mid-sized and start-up biopharmaceutical manufacturers including UCB, Amgen, and Sepracor.

“We are thrilled with the high level of commercial strategy, market access, and pricing and contracting experience Bruce brings to the table,” said, Viscadia President and CEO, Satish Kauta.

Yeager’s biopharmaceutical experience extends to developing commercial marketing and sales strategies that have resulted in increased product revenue and reduced commercial operating expenses. Yeager earned an EMBA from the W. P. Carey School of Business at Arizona State University and a BA in business administration from Washington & Jefferson College.

Viscadia Inc. is an analytically driven management consulting firm that partners with companies in specialty pharmaceutical markets. Viscadia identifies and evaluates development, acquisition, licensing and life-cycle management opportunities. Additionally, Viscadia analyzes and optimizes the execution of specialty pharmaceutical commercial strategies. Viscadia is headquartered in Washington, D.C., with regional offices in San Diego, CA, and St. Louis, MO. For more information about Viscadia, email info@viscadia.com, call 202-540-9900 or visit www.viscadia.com.

Contact: Amy Zimmerman
A.Z. Communications
619-501-1875
amy@azcommunications.net

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES